Trial Profile
Clinical Trials Insight: 700055171
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Apr 2010
Price :
$35
*
At a glance
- Drugs Chiglitazar (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Chipscreen Biosciences
- 23 Apr 2007 Positive results have been reported in a Chipscreen media release.
- 23 Apr 2007 New trial record